FCA Corp’s GSK GSK Stock Holding History

FCA Corp’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,800	Closed	-$200K	–	165
2022 Q3	$200K	Hold	6,800	–	–	0.08%	142
2022 Q2	$370K	Hold	6,800	–	–	0.15%	122
2022 Q1	$370K	Hold	6,800	–	–	0.13%	129
2021 Q4	$375K	Hold	6,800	–	–	0.13%	138
2021 Q3	$351K	Hold	6,800	–	–	0.11%	108
2021 Q2	$338K	Hold	6,800	–	–	0.1%	143
2021 Q1	$304K	Hold	6,800	–	–	0.09%	148
2020 Q4	$313K	Buy	+6,800	New	+$312K	0.1%	138
2020 Q3	–	Sell	-6,800	Closed	-$347K	–	209
2020 Q2	$347K	Hold	6,800	–	–	0.13%	113
2020 Q1	$322K	Hold	6,800	–	–	0.14%	110
2019 Q4	$399K	Hold	6,800	–	–	0.14%	113
2019 Q3	$363K	Hold	6,800	–	–	0.14%	111
2019 Q2	$340K	Buy	6,800 +1,600	+31%	+$80.3K	0.12%	115
2019 Q1	$272K	Hold	5,200	–	–	0.11%	118
2018 Q4	$248K	Hold	5,200	–	–	0.11%	115
2018 Q3	$261K	Hold	5,200	–	–	0.1%	127
2018 Q2	$262K	Hold	5,200	–	–	0.1%	125
2018 Q1	$254K	Hold	5,200	–	–	0.1%	127
2017 Q4	$231K	Hold	5,200	–	–	0.09%	139
2017 Q3	$264K	Hold	5,200	–	–	0.11%	126
2017 Q2	$280K	Hold	5,200	–	–	0.12%	112
2017 Q1	$274K	Hold	5,200	–	–	0.13%	112
2016 Q4	$250K	Buy	+5,200	New	+$257K	0.12%	118
2016 Q3	–	Sell	-5,200	Closed	-$282K	–	140
2016 Q2	$282K	Buy	5,200 +800	+18%	+$42.1K	0.14%	110
2016 Q1	$223K	Buy	+4,400	New	+$219K	0.12%	122

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

FCA Corp's GSK Position: Q4 2022 in Review

FCA Corp sold out of GSK (GSK) in Q4 2022, closing a stake of 6,800 shares — an estimated $200K sold.

FCA Corp first reported a position in GSK in Q1 2016 and held it in 25 quarters. The position peaked at $399K in Q4 2019. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

FCA Corp reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
FCA Corp sold 6,800 GSK shares in Q4 2022, an estimated $200K.
FCA Corp first reported a position in GSK in Q1 2016 and held it in 25 quarters.
FCA Corp's GSK position peaked at $399K in Q4 2019.
813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on FCA Corp's 13F filing for Q4 2022, filed 14 Feb 2023.